The approach doesn’t involve a hot new drug or technology. Instead, it’s based on being smarter about using the longtime mainstay treatments for ovarian cancer: surgery and chemotherapy.
Using the strategy, which involves assigning a score on the severity of the cancer to guide treatment, doctors at University of Texas MD Anderson Cancer Center in Houston have succeeded in removing all visible disease in 86% of treated women over the past two years. That’s more than quadruple the 20% rate the doctors had achieved before starting the protocol.
The doctors haven’t yet proved that the strategy will extend lives, but they’re anticipating a dramatic impact. Other recent studies indicate that complete surgical removal of visible disease doubles the chances—to more than 60%—that a woman will survive at least five years after diagnosis..
Read more
Using the strategy, which involves assigning a score on the severity of the cancer to guide treatment, doctors at University of Texas MD Anderson Cancer Center in Houston have succeeded in removing all visible disease in 86% of treated women over the past two years. That’s more than quadruple the 20% rate the doctors had achieved before starting the protocol.
The doctors haven’t yet proved that the strategy will extend lives, but they’re anticipating a dramatic impact. Other recent studies indicate that complete surgical removal of visible disease doubles the chances—to more than 60%—that a woman will survive at least five years after diagnosis..
Read more
RSS Feed
